ABT-165
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-165, covering 2021-02-09 to 2021-02-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab [Phase 2]